首页> 外国专利> COMBINATION OF A RTK INHIBITOR WITH AN ANTI - ESTROGEN AND USE THEREOF FOR THE TREATMENT OF CANCER

COMBINATION OF A RTK INHIBITOR WITH AN ANTI - ESTROGEN AND USE THEREOF FOR THE TREATMENT OF CANCER

机译:RTK抑制剂与抗雌激素的结合及其在癌症治疗中的应用。

摘要

A pharmaceutical combination comprising (a) a RTK inhibitor selected from the group consisting of compounds of Formula I or a tautomer thereof, compounds of Formula II or a tautomer thereof, compounds of Formula III or a tautomer thereof, a pharmaceutically acceptable salt of the compound, a pharmaceutically acceptable salt of the tautomer, or a mixture thereof; and (b) one or more anti-estrogen compounds, or a pharmaceutically acceptable salt thereof; such as tamoxifen, toremifene, fulvestrant, raloxifene or raloxifene hydrochloride; the uses of such combination in the treatment or prevention of proliferative diseases: and methods of treating a subject suffering from a proliferative disease; and methods of treating a subject suffering from a proliferative disease comprising administering a therapeutically effective amount of such combination.
机译:药物组合,其包含(a)选自式I的化合物或其互变异构体,式II的化合物或其互变异构体,式III的化合物或其互变异构体的RTK抑制剂,该化合物的药学上可接受的盐,互变异构体的药学上可接受的盐或其混合物; (b)一种或多种抗雌激素化合物或其药学上可接受的盐;如他莫昔芬,托瑞米芬,氟维司群,雷洛昔芬或雷洛昔芬盐酸盐;这种组合在治疗或预防增生性疾病中的用途:以及治疗患有增生性疾病的受试者的方法;和治疗患有增生性疾病的受试者的方法,包括施用治疗有效量的此类组合。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号